Absolute Bioavailability and Dose Proportionality of BMS-181885, an Antimigraine Agent, Following the Administration of Single Intranasal Doses to Cynomolgus Monkeys
- 1 September 1998
- journal article
- research article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 87 (9) , 1170-1172
- https://doi.org/10.1021/js9802042
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Pharmacokinetic and Pharmacodynamic Response after Intranasal Administration of Diazepam to RabbitsJournal of Pharmacy and Pharmacology, 1997
- Safety, Tolerability, and Pharmacokinetics of Sumatriptan in Healthy Subjects Following Ascending Single Intranasal Doses and Multiple Intranasal DosesCephalalgia, 1997
- Transnasal ButorphanolDrugs, 1995
- Lack of Pharmacokinetic Interaction Between Butorphanol Tartrate Nasal Spray and Sumatriptan SuccinateThe Journal of Clinical Pharmacology, 1995
- Intranasal Versus Intravenous Neostigmine in Myasthenia GravisClinical Neuropharmacology, 1993
- The application of statistical moment theory to the evaluation ofin vivo dissolution time and absorption timeJournal of Pharmacokinetics and Biopharmaceutics, 1980
- Responsiveness of Isolated Cerebral and Peripheral Arteries to Serotonin, Norepinephrine, and Transmural Electrical StimulationCirculation Research, 1973
- ABOLITION OF PAIN BY ELECTRICAL STIMULATIONHeadache: The Journal of Head and Face Pain, 1967
- Serotonin, the Carotid Body, and Cranial Vessels in MigraineArchives of Neurology, 1967
- Effect of serotonin in migraine patientsNeurology, 1960